Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.

Shao J, Zaro JL, Shen WC.

Tissue Barriers. 2016 Mar 4;4(2):e1156804. doi: 10.1080/21688370.2016.1156804. eCollection 2016 Apr-Jun. Review.

PMID:
27358753
2.

Albumen Transport to Bruch's Membrane and RPE by Choriocapillaris Caveolae.

Nakanishi M, Grebe R, Bhutto IA, Edwards M, McLeod DS, Lutty GA.

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2213-24. doi: 10.1167/iovs.15-17934.

PMID:
27116549
3.

Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.

Adjei IM, Sharma B, Peetla C, Labhasetwar V.

J Control Release. 2016 Jun 28;232:83-92. doi: 10.1016/j.jconrel.2016.04.019. Epub 2016 Apr 15.

PMID:
27090164
4.

Long-Term Toxicity of 213Bi-Labelled BSA in Mice.

Dorso L, Bigot-Corbel E, Abadie J, Diab M, Gouard S, Bruchertseifer F, Morgenstern A, Maurel C, Chérel M, Davodeau F.

PLoS One. 2016 Mar 16;11(3):e0151330. doi: 10.1371/journal.pone.0151330. eCollection 2016.

5.

Cellular distribution of injected PLGA-nanoparticles in the liver.

Park JK, Utsumi T, Seo YE, Deng Y, Satoh A, Saltzman WM, Iwakiri Y.

Nanomedicine. 2016 Jul;12(5):1365-74. doi: 10.1016/j.nano.2016.01.013. Epub 2016 Mar 4.

PMID:
26961463
6.

Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles.

Carlander U, Li D, Jolliet O, Emond C, Johanson G.

Int J Nanomedicine. 2016 Feb 11;11:625-40. doi: 10.2147/IJN.S94370. eCollection 2016.

7.

Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.

Owen A, Rannard S.

Adv Drug Deliv Rev. 2016 Aug 1;103:144-56. doi: 10.1016/j.addr.2016.02.003. Epub 2016 Feb 23. Review.

PMID:
26916628
8.
9.

Melanoma growth effects on molecular clearance from tumors and biodistribution into systemic tissues versus draining lymph nodes.

Rohner NA, Thomas SN.

J Control Release. 2016 Feb 10;223:99-108. doi: 10.1016/j.jconrel.2015.12.027. Epub 2015 Dec 23.

PMID:
26721446
10.
11.

Magnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine.

Bao Y, Wen T, Samia AC, Khandhar A, Krishnan KM.

J Mater Sci. 2016 Jan;51(1):513-553. Epub 2015 Sep 1.

PMID:
26586919
12.

Shape-Dependent Skin Penetration of Silver Nanoparticles: Does It Really Matter?

Tak YK, Pal S, Naoghare PK, Rangasamy S, Song JM.

Sci Rep. 2015 Nov 20;5:16908. doi: 10.1038/srep16908.

13.

Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy.

Gkretsi V, Stylianou A, Papageorgis P, Polydorou C, Stylianopoulos T.

Front Oncol. 2015 Oct 14;5:214. doi: 10.3389/fonc.2015.00214. eCollection 2015. Review.

14.

Ameliorating Role Exerted by Al-Hijamah in Autoimmune Diseases: Effect on Serum Autoantibodies and Inflammatory Mediators.

Baghdadi H, Abdel-Aziz N, Ahmed NS, Mahmoud HS, Barghash A, Nasrat A, Nabo MM, El Sayed SM.

Int J Health Sci (Qassim). 2015 Apr;9(2):207-32. Review.

15.

Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.

Katsumi H, Sano J, Nishikawa M, Hanzawa K, Sakane T, Yamamoto A.

PLoS One. 2015 Aug 19;10(8):e0135966. doi: 10.1371/journal.pone.0135966. eCollection 2015.

16.

Design considerations for nanotherapeutics in oncology.

Stylianopoulos T, Jain RK.

Nanomedicine. 2015 Nov;11(8):1893-907. doi: 10.1016/j.nano.2015.07.015. Epub 2015 Aug 15. Review.

PMID:
26282377
17.
18.

Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid.

Baronzio G, Parmar G, Baronzio M.

Front Oncol. 2015 Jul 23;5:165. doi: 10.3389/fonc.2015.00165. eCollection 2015. Review.

19.

Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.

Durymanov MO, Rosenkranz AA, Sobolev AS.

Theranostics. 2015 Jun 8;5(9):1007-20. doi: 10.7150/thno.11742. eCollection 2015. Review.

20.

Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments.

Bachler G, Losert S, Umehara Y, von Goetz N, Rodriguez-Lorenzo L, Petri-Fink A, Rothen-Rutishauser B, Hungerbuehler K.

Part Fibre Toxicol. 2015 Jun 27;12:18. doi: 10.1186/s12989-015-0090-8.

Items per page

Supplemental Content

Write to the Help Desk